Cellectar Biosciences, Inc.
CLRBHealthcare|Biotechnology|US
$1.25
+0.10 (+8.70%)
DCF Value
$4.39
Tangible Book / Share
$2.44
Cash / Share
$2.78
Ownership Breakdown
98.2%
Float
9.5M
Shares Outstanding
9.3M
Float Shares
Major Holders (37)
Combined: 282.7%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| SilverArc Capital Management, LLC | Investment adviser | 9.99% | 851,285 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management L.P. | IA, PN | 9.99% | 798,382 | Aug 14, 2026 | 13D/G |
| Bam GP LLC | HC, OO | 9.99% | 798,382 | Aug 14, 2026 | 13D/G |
| Balyasny Asset Management Holdings LP | HC, PN | 9.99% | 798,382 | Aug 14, 2026 | 13D/G |
| Dames GP LLC | HC, OO | 9.99% | 798,382 | Aug 14, 2026 | 13D/G |
| Dmitry Balyasny | HC, IN | 9.99% | 798,382 | Aug 14, 2026 | 13D/G |
| Devesh Gandhi | Individual | 9.99% | 851,285 | Aug 14, 2026 | 13D/G |
| Bleichroeder LP | Investment adviser | 9.99% | 808,300 | Aug 13, 2026 | 13D/G |
| Andrew Gundlach | Holding company | 9.99% | 808,300 | Aug 13, 2026 | 13D/G |
| Bleichroeder Holdings LLC | Holding company | 9.99% | 808,300 | Aug 13, 2026 | 13D/G |
| Empery Asset Management, LP | IA, PN | 9.99% | 864,090 | Aug 4, 2026 | 13D/G |
| Ryan M. Lane | HC, IN | 9.99% | 864,090 | Aug 4, 2026 | 13D/G |
| Janus Henderson Group PLC | Holding company | 9.99% | 798,382 | Jun 5, 2026 | 13D/G |
| Laurence W. Lytton | Individual | 9.99% | 4,389,969 | Nov 14, 2024 | 13D/G |
| Michelle Ross | HC, IN | 9.90% | 845,740 | Aug 14, 2026 | 13D/G |
| StemPoint Capital Management GP LLC | Other | 9.90% | 845,740 | Aug 14, 2026 | 13D/G |
| StemPoint Capital LP | IA, PN | 9.90% | 845,740 | Aug 14, 2026 | 13D/G |
| Stonepine Capital, L.P. | Partnership | 9.90% | 863,277 | May 11, 2026 | 13D/G |
| Stonepine GP, LLC | Other | 9.90% | 863,277 | May 11, 2026 | 13D/G |
| Stonepine Capital Management, LLC | IA, OO | 9.90% | 863,277 | May 11, 2026 | 13D/G |
| Jon M. Plexico | HC, IN | 9.90% | 863,277 | May 11, 2026 | 13D/G |
| ADAR1 Capital Management, LLC | Other | 8.51% | 3,684,708 | Nov 14, 2024 | 13D/G |
| Daniel Schneeberger | Individual | 8.51% | 3,684,708 | Nov 14, 2024 | 13D/G |
| ADAR1 Capital Management GP, LLC | Other | 8.42% | 3,645,155 | Nov 14, 2024 | 13D/G |
| Caligan Partners LP | IA, PN | 5.90% | 469,998 | Aug 14, 2026 | 13D/G |
| Johnson David Edward | HC, IN | 5.90% | 469,998 | Aug 14, 2026 | 13D/G |
| Mitchell P. Kopin | HC, IN | 4.99% | 140,101 | Jul 8, 2025 | 13D/G |
| Intracoastal Capital LLC | Other | 4.99% | 140,101 | Jul 8, 2025 | 13D/G |
| Daniel B. Asher | HC, IN | 4.99% | 140,101 | Jul 8, 2025 | 13D/G |
| Hexstone Capital LLC | Other | 4.90% | 216,130 | Feb 4, 2026 | 13D/G |
| Brendan O'Neil | Individual | 4.90% | 216,130 | Feb 4, 2026 | 13D/G |
| Orin Hirschman | HC, IN | 4.90% | 2,022,221 | Jan 27, 2025 | 13D/G |
| AIGH Capital Management LLC | IA, OO | 4.90% | 2,022,221 | Jan 27, 2025 | 13D/G |
| Lytton Laurence W | Individual | 1.60% | 51,391 | Aug 14, 2025 | 13D/G |
| Nantahala Capital Management, LLC | Investment adviser | 0.06% | 1,109 | Aug 14, 2025 | 13D/G |
| Wilmot B. Harkey | Holding company | 0.06% | 1,109 | Aug 14, 2025 | 13D/G |
| Daniel Mack | Holding company | 0.06% | 1,109 | Aug 14, 2025 | 13D/G |
Insider Trades (100)
Last 4 quarters: 746,940 acquired · 198 disposed
| Insider | Position | Date | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Loren Stefan | other: Consultant | Jul 8, 2026 | AWARD | 15,000 | $2.69 | $40.4K | Form 4 |
| Kolean Chad J | CFO | Jul 7, 2026 | AWARD | 92,000 | $3.14 | $288.9K | Form 4 |
| DRISCOLL FREDERICK W | director | Jul 7, 2026 | AWARD | 25,000 | $2.70 | $67.5K | Form 4 |
| Chanan-Khan Asher | director | Jul 7, 2026 | AWARD | 25,000 | $2.70 | $67.5K | Form 4 |
| CARUSO JAMES V | director, officer: President & CEO | Jul 7, 2026 | AWARD | 250,000 | $3.14 | $785.0K | Form 4 |
| Gu Andrew | director | Jul 7, 2026 | AWARD | 25,000 | $2.70 | $67.5K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jul 7, 2026 | AWARD | 118,000 | $3.14 | $370.5K | Form 4 |
| Swirsky Douglas J | director | Jul 7, 2026 | AWARD | 37,500 | $2.70 | $101.3K | Form 4 |
| NEIS JOHN | director | Jul 7, 2026 | AWARD | 25,000 | $2.70 | $67.5K | Form 4 |
| Loren Stefan | other: Consultant | Jul 8, 2026 | AWARD | 15,000 | $2.68 | $40.2K | Form 4 |
| Gu Andrew | director: | May 18, 2026 | OTHER | 0 | — | — | Form 4 |
| Longcor Jarrod | Chief Operating Officer | May 7, 2026 | BUY | 26,040 | $2.88 | $75.0K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | May 7, 2026 | BUY | 8,680 | $2.88 | $25.0K | Form 4 |
| CARUSO JAMES V | director, officer: Chief Executive Officer | May 7, 2026 | BUY | 26,040 | $2.88 | $75.0K | Form 4 |
| CARUSO JAMES V | director, officer: Chief Executive Officer | May 7, 2026 | BUY | 8,680 | $2.88 | $25.0K | Form 4 |
| NEIS JOHN | director | Dec 12, 2025 | SELL | 198 | $3.70 | $731.99 | Form 4 |
| CARUSO JAMES V | director, officer: Chief Executive Officer | Jul 2, 2025 | BUY | 10,000 | $4.99 | $49.9K | Form 4 |
| CARUSO JAMES V | director, officer: Chief Executive Officer | Jul 2, 2025 | BUY | 10,000 | $5.25 | $52.5K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jul 2, 2025 | BUY | 10,000 | $4.99 | $49.9K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jul 2, 2025 | BUY | 10,000 | $5.25 | $52.5K | Form 4 |
| Kolean Chad J | Chief Financial Officer | Jul 2, 2025 | BUY | 5,000 | $4.99 | $24.9K | Form 4 |
| Kolean Chad J | Chief Financial Officer | Jul 2, 2025 | BUY | 5,000 | $5.25 | $26.3K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jan 10, 2025 | BUY | 30,000 | $0.28 | $8.4K | Form 4 |
| Swirsky Douglas J | director | Feb 14, 2025 | AWARD | 90,000 | $0.29 | $26.1K | Form 4 |
| NEIS JOHN | director | Feb 14, 2025 | AWARD | 60,000 | $0.29 | $17.4K | Form 4 |
| Loren Stefan | director | Feb 14, 2025 | AWARD | 60,000 | $0.29 | $17.4K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Feb 14, 2025 | AWARD | 500,000 | $0.29 | $145.0K | Form 4 |
| Kolean Chad J | Chief Financial Officer | Feb 14, 2025 | AWARD | 290,000 | $0.29 | $84.1K | Form 4 |
| DRISCOLL FREDERICK W | director | Feb 14, 2025 | AWARD | 60,000 | $0.29 | $17.4K | Form 4 |
| Chanan-Khan Asher | director | Feb 14, 2025 | AWARD | 60,000 | $0.29 | $17.4K | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Feb 14, 2025 | AWARD | 900,000 | $0.29 | $261.0K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jun 14, 2024 | AWARD | 500,000 | $2.65 | $1.3M | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Jun 14, 2024 | AWARD | 900,000 | $2.65 | $2.4M | Form 4 |
| Kolean Chad J | Chief Financial Officer | Jun 14, 2024 | AWARD | 290,000 | $2.65 | $768.5K | Form 4 |
| Shustov Andrei | Senior Vice President, Medical | Jun 14, 2024 | AWARD | 260,000 | $2.65 | $689.0K | Form 4 |
| Lea Darrell Shane | Chief Commercial Officer | Jun 14, 2024 | AWARD | 260,000 | $2.65 | $689.0K | Form 4 |
| Loren Stefan | director | Jun 14, 2024 | AWARD | 60,000 | $2.58 | $154.8K | Form 4 |
| Swirsky Douglas J | director | Jun 14, 2024 | AWARD | 90,000 | $2.58 | $232.2K | Form 4 |
| NEIS JOHN | director | Jun 14, 2024 | AWARD | 60,000 | $2.58 | $154.8K | Form 4 |
| DRISCOLL FREDERICK W | director | Jun 14, 2024 | AWARD | 60,000 | $2.58 | $154.8K | Form 4 |
| Chanan-Khan Asher | director | Jun 14, 2024 | AWARD | 60,000 | $2.58 | $154.8K | Form 4 |
| Lea Darrell Shane | Chief Commercial Officer | Jun 23, 2023 | AWARD | 100,000 | $1.68 | $168.0K | Form 4 |
| Lea Darrell Shane | Chief Commercial Officer | Dec 8, 2023 | AWARD | 39,599 | — | — | Form 4 |
| Kolean Chad J | Chief Financial Officer | Jun 23, 2023 | AWARD | 104,000 | $1.68 | $174.7K | Form 4 |
| Kolean Chad J | Chief Financial Officer | Dec 8, 2023 | AWARD | 42,554 | — | — | Form 4 |
| Shustov Andrei | Senior Vice President, Medical | Dec 8, 2023 | AWARD | 47,856 | — | — | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jun 23, 2023 | AWARD | 144,000 | $1.68 | $241.9K | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Dec 8, 2023 | AWARD | 42,927 | — | — | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Jun 23, 2023 | AWARD | 261,000 | $1.68 | $438.5K | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Dec 8, 2023 | AWARD | 40,596 | — | — | Form 4 |
| Swirsky Douglas J | director | Jun 28, 2023 | AWARD | 37,500 | $1.85 | $69.4K | Form 4 |
| NEIS JOHN | director | Jun 28, 2023 | AWARD | 25,000 | $1.85 | $46.3K | Form 4 |
| Loren Stefan | director | Jun 28, 2023 | AWARD | 25,000 | $1.85 | $46.3K | Form 4 |
| DRISCOLL FREDERICK W | director | Jun 28, 2023 | AWARD | 25,000 | $1.85 | $46.3K | Form 4 |
| Chanan-Khan Asher | director | Jun 28, 2023 | AWARD | 25,000 | $1.85 | $46.3K | Form 4 |
| Shustov Andrei | Senior Vice President, Medical | Feb 15, 2023 | AWARD | 100,000 | $1.67 | $167.0K | Form 4 |
| Shustov Andrei | Senior Vice President, Medical | Feb 15, 2023 | DISPOSED | 0 | — | — | Form 4 |
| Longcor Jarrod | Chief Operating Officer | Jan 17, 2023 | AWARD | 144,000 | — | — | Form 4 |
| CARUSO JAMES V | President and CEO | Jan 17, 2023 | AWARD | 261,000 | — | — | Form 4 |
| Kolean Chad J | Chief Financial Officer | Jan 17, 2023 | AWARD | 104,000 | — | — | Form 4 |
| Lea Darrell Shane | director: Chief Commercial Officer | Nov 21, 2022 | AWARD | 100,000 | — | — | Form 4 |
| Lea Darrell Shane | Nov 21, 2022 | OTHER | — | — | — | Form 4 | |
| Lea Darrell Shane | Nov 21, 2022 | OTHER | 0 | — | — | Form 4 | |
| Swirsky Douglas J | director: | Jun 24, 2022 | AWARD | 11,700 | — | — | Form 4 |
| Swirsky Douglas J | director | Jun 24, 2022 | AWARD | 11,700 | $4.10 | $48.0K | Form 4 |
| NEIS JOHN | director: | Jun 24, 2022 | AWARD | 7,800 | — | — | Form 4 |
| Loren Stefan | director: | Jun 24, 2022 | AWARD | 7,800 | — | — | Form 4 |
| Loren Stefan | director | Jun 24, 2022 | AWARD | 7,800 | $4.10 | $32.0K | Form 4 |
| DRISCOLL FREDERICK W | director: | Jun 24, 2022 | AWARD | 7,800 | — | — | Form 4 |
| Chanan-Khan Asher | director: | Jun 24, 2022 | AWARD | 7,800 | — | — | Form 4 |
| Kolean Chad J | Chief Financial Officer | Feb 24, 2022 | DISPOSED | 0 | — | — | Form 4 |
| Kolean Chad J | Feb 22, 2022 | AWARD | 150,000 | $0.49 | $73.5K | Form 4 | |
| Kolean Chad J | Feb 22, 2022 | OTHER | 0 | — | — | Form 4 | |
| Longcor Jarrod | Chief Business Officer | Jan 25, 2022 | AWARD | 475,000 | $0.55 | $261.3K | Form 4 |
| Elefant Dov | Chief Financial Officer | Jan 25, 2022 | AWARD | 422,000 | $0.55 | $232.1K | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Jan 25, 2022 | AWARD | 1,419,000 | $0.55 | $780.5K | Form 4 |
| Swirsky Douglas J | director | Sep 14, 2021 | BUY | 25,000 | $1.04 | $26.0K | Form 4 |
| DRISCOLL FREDERICK W | director | Sep 3, 2021 | BUY | 19,417 | $1.04 | $20.2K | Form 4 |
| Swirsky Douglas J | director | Jun 30, 2021 | AWARD | 117,000 | $1.19 | $139.2K | Form 4 |
| Loren Stefan | director | Jun 30, 2021 | AWARD | 78,000 | $1.19 | $92.8K | Form 4 |
| NEIS JOHN | director | Jun 30, 2021 | AWARD | 78,000 | $1.19 | $92.8K | Form 4 |
| DRISCOLL FREDERICK W | director | Jun 30, 2021 | AWARD | 78,000 | $1.19 | $92.8K | Form 4 |
| Chanan-Khan Asher | director | Jun 30, 2021 | AWARD | 78,000 | $1.19 | $92.8K | Form 4 |
| Chanan-Khan Asher | director: | Jun 23, 2021 | OTHER | 0 | — | — | Form 4 |
| NEIS JOHN | director | Mar 17, 2021 | SELL | 58,640 | $30.40 | $1.8M | Form 4 |
| NEIS JOHN | director | Mar 18, 2021 | SELL | 23,232 | $30.40 | $706.3K | Form 4 |
| NEIS JOHN | director | Mar 12, 2021 | SELL | 41,155 | $30.40 | $1.3M | Form 4 |
| NEIS JOHN | director | Mar 15, 2021 | SELL | 11,200 | $30.40 | $340.5K | Form 4 |
| NEIS JOHN | director | Mar 16, 2021 | SELL | 100,515 | $30.40 | $3.1M | Form 4 |
| Elefant Dov | Chief Financial Officer | Mar 4, 2021 | AWARD | 430,000 | $1.74 | $748.2K | Form 4 |
| Longcor Jarrod | Chief Business Officer | Mar 4, 2021 | AWARD | 450,000 | $1.74 | $783.0K | Form 4 |
| Friend John E. II | Chief Medical Officer | Mar 4, 2021 | AWARD | 330,000 | $1.74 | $574.2K | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Mar 4, 2021 | AWARD | 1,600,000 | $1.74 | $2.8M | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Mar 4, 2021 | BUY | 5,100 | $1.70 | $8.7K | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Mar 4, 2021 | SELL | 46,948 | $30.40 | $1.4M | Form 4 |
| CARUSO JAMES V | director, officer: President and CEO | Dec 28, 2020 | BUY | 37,037 | $1.35 | $50.0K | Form 4 |
| Longcor Jarrod | Chief Business Officer | Dec 28, 2020 | BUY | 29,630 | $1.35 | $40.0K | Form 4 |
| Elefant Dov | Chief Financial Officer | Dec 28, 2020 | BUY | 7,407 | $1.35 | $10.0K | Form 4 |
| Friend John E. II | VP, Chief Medical Officer | Jul 1, 2020 | AWARD | 100,000 | $1.34 | $134.0K | Form 4 |
| Friend John E. II | VP, Chief Medical Officer | Jul 1, 2020 | DISPOSED | 0 | — | — | Form 4 |